Vanarix was founded in 2018.
Headquarted in Lausanne, Switzerland. The company has a research group working at the faculty of medicine in Geneva strategically located near university hospitals of Geneva, for translational research dedicated to patients
Vanarix developed and patented an innovative advanced cell therapy medicinal product to repair cartilage defects
Overview of Vanarix’s collaborations and timeline :